Ignite Creation Date:
2024-05-05 @ 11:20 AM
Last Modification Date:
2024-10-26 @ 9:01 AM
Study NCT ID:
NCT00000244
Status:
COMPLETED
Last Update Posted:
2015-05-27
First Post:
1999-09-20
Brief Title:
Effects of Dynorphin 1-13 on Heroin Addiction - 1
Sponsor:
University of Minnesota
Organization:
University of Minnesota
Study Overview
Official Title:
Effects of Dynorphin 1-13 on Heroin Addiction
Status:
COMPLETED
Status Verified Date:
2015-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the effects of IV dynorphin in humans during acute heroin abstinence in order to determine that dynorphin suppresses acute opiate withdrawal reduces opiate craving and is safe at doses required to produce the above effects
Detailed Description:
Randomized double blinded study of the effects of a single IV dose of dynorphin A 1-13 on heroin withdrawal in human opiate addicts
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| R01-08067-1 | US NIH GrantContract | None | httpsreporternihgovquickSearchR01DA008067 |
| R01DA008067 | NIH | None | None |